KEGG   DRUG: Camidanlumab
Entry
D11324                      Drug                                   
Name
Camidanlumab (USAN)
Formula
C6398H9946N1714O1992S42
Exact mass
144005.7935
Mol weight
144094.53
Sequence
(Heavy chain)
QVQLVQSGAE VKKPGSSVKV SCKASGGTFS RYIINWVRQA PGQGLEWMGR IIPILGVENY
AQKFQGRVTI TADKSTSTAY MELSSLRSED TAVYYCARKD WFDYWGQGTL VTVSSASTKG
PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
SSVVTVPSSS LGTQTYICNV NHKPSNTKVD KRVEPKSCDK THTCPPCPAP ELLGGPSVFL
FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV
VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSREEMTKNQ
VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV
FSCSVMHEAL HNHYTQKSLS LSPGK
(Light chain)
EIVLTQSPGT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYG ASSRATGIPD
RFSGSGSGTD FTLTISRLEP EDFAVYYCQQ YGSSPLTFGG GTKVEIKRTV AAPSVFIFPP
SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
(Disulfide bridge: H22-H96, H142-H198, H218-L-214, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'96, H'142-H'198, H'218-L'214, H'259-H'319, H'365-H'423, L23-L88 L134-L194, L'23-L'88, L'134-L'194)
  Type
Peptide
Efficacy
Antineoplasitc, Anti-IL-2 receptor alpha antibody
  Type
Monoclonal antibody
Comment
Treatment of hematologic cancers
Target
IL2RA (CD25) [HSA:3559] [KO:K05068]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04640  Hematopoietic cell lineage
Brite
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interleukin receptors
    IL2RA (CD25)
     D11324  Camidanlumab (USAN)
Other DBs
CAS: 921618-45-3
PubChem: 384585302
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system